Literature DB >> 26899494

Gender, Race, and Health Insurance Status in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Nileshkumar Patel1, Abhishek Deshmukh2, Badal Thakkar3, James O Coffey1, Kanishk Agnihotri4, Achint Patel5, Nitesh Ainani6, Nikhil Nalluri7, Nilay Patel4, Nish Patel1, Neil Patel5, Apurva O Badheka8, Marcin Kowalski7, Robert Hendel1, Juan Viles-Gonzalez1, Peter A Noseworthy2, Samuel Asirvatham2, Kaming Lo1, Robert J Myerburg1, Raul D Mitrani9.   

Abstract

Catheter ablation for atrial fibrillation (AF) has emerged as a popular procedure. The purpose of this study was to examine whether there exist differences or disparities in ablation utilization across gender, socioeconomic class, insurance, or race. Using the Nationwide Inpatient Sample (2000 to 2012), we identified adults hospitalized with a principal diagnosis of AF by ICD 9 code 427.31 who had catheter ablation (ICD 9 code-37.34). We stratified patients by race, insurance status, age, gender, and hospital characteristics. A hierarchical multivariate mixed-effect model was created to identify the independent predictors of AF ablation. Among an estimated total of 3,508,122 patients (extrapolated from 20% Nationwide Inpatient Sample) hospitalized with a diagnosis of AF in the United States from the year 2000 to 2012, 102,469 patients (2.9%) underwent catheter ablations. The number of ablations was increased by 940%, from 1,439 in 2000 to 15,090 in 2012. There were significant differences according to gender, race, and health insurance status, which persisted even after adjustment for other risk factors. Female gender (0.83 [95% CI 0.79 to 0.87; p <0.001]), black (0.49 [95% CI 0.44 to 0.55; p <0.001]), and Hispanic race (0.64 [95% CI 0.56 to 0.72; p <0.001]) were associated with lower likelihoods of undergoing an AF ablation. Medicare (0.93, 0.88 to 0.98, <0.001) or Medicaid (0.67, 0.59 to 0.76, <0.001) coverage and uninsured patients (0.55, 0.49 to 0.62, <0.001) also had lower rates of AF ablation compared to patients with private insurance. In conclusion we found differences in utilization of catheter ablation for AF based on gender, race, and insurance status that persisted over time.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26899494     DOI: 10.1016/j.amjcard.2016.01.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14.

Authors:  Jim W Cheung; Edward P Cheng; Xian Wu; Ilhwan Yeo; Paul J Christos; Hooman Kamel; Steven M Markowitz; Christopher F Liu; George Thomas; James E Ip; Bruce B Lerman; Luke K Kim
Journal:  Eur Heart J       Date:  2019-09-21       Impact factor: 29.983

2.  Impact of race and gender on clinical outcomes of catheter ablation in patients with atrial fibrillation.

Authors:  Abdallah Bukari; Hemal Nayak; Zaid Aziz; Amrish Deshmukh; Roderick Tung; Cevher Ozcan
Journal:  Pacing Clin Electrophysiol       Date:  2017-09-20       Impact factor: 1.976

Review 3.  Atrial fibrillation in women: treatment.

Authors:  Darae Ko; Faisal Rahman; Maria A P Martins; Elaine M Hylek; Patrick T Ellinor; Renate B Schnabel; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-10-27       Impact factor: 32.419

Review 4.  Update on Management of Cardiovascular Diseases in Women.

Authors:  Fabiana Lucà; Maurizio Giuseppe Abrignani; Iris Parrini; Stefania Angela Di Fusco; Simona Giubilato; Carmelo Massimiliano Rao; Laura Piccioni; Laura Cipolletta; Bruno Passaretti; Francesco Giallauria; Angelo Leone; Giuseppina Maura Francese; Carmine Riccio; Sandro Gelsomino; Furio Colivicchi; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

5.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

6.  California study of Ablation (CAABL):early utilization after index hospitalization for non-valvular atrial fibrillation.

Authors:  Uma Srivatsa; Beate Danielsen; Ezra Amsterdam; Yingbo Yang; Dali Fan; Nayereh Pezeshkian; Richard H White
Journal:  J Atr Fibrillation       Date:  2017-06-30

7.  Debates in allergy medicine: Molecular allergy diagnosis with ISAC will replace screenings by skin prick test in the future.

Authors:  E Jensen-Jarolim; A N Jensen; G W Canonica
Journal:  World Allergy Organ J       Date:  2017-09-19       Impact factor: 4.084

Review 8.  Social determinants of atrial fibrillation.

Authors:  Utibe R Essien; Jelena Kornej; Amber E Johnson; Lucy B Schulson; Emelia J Benjamin; Jared W Magnani
Journal:  Nat Rev Cardiol       Date:  2021-06-02       Impact factor: 32.419

9.  Paroxysmal Atrial Fibrillation in Females: Understanding gender diferences.

Authors:  Gabriel Odozynski; Alexander Romeno Janner Dal Forno; Andrei Lewandowski; Hélcio Garcia Nascimento; André d'Avila
Journal:  Arq Bras Cardiol       Date:  2018-05-03       Impact factor: 2.000

10.  Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure.

Authors:  Michelle Samuel; Michal Abrahamowicz; Jacqueline Joza; Vidal Essebag; Louise Pilote
Journal:  CJC Open       Date:  2020-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.